A Randomized Trial of Oral Naltrexone for Treating Opioid-Dependent Offenders

por Coviello, Donna M., Cornish, James W., Lynch, Kevin G., Alterman, Arthur I., O’Brien, Charles P.
Publicado 2010

Naltrexone Maintenance: Effect on Morphine Sensitivity in Normal Volunteers

por Cornish, James W., Henson, David, Levine, Sanford, Volpicelli, Joseph, Inturrisi, Charles E., Yoburn, Byron C., O’Brien, Charles P.
Publicado en Am J Addict (1993)

Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioid use disorder

por Crist*, Richard. C., Phillips, Karran. A., Furnari, Melody. A., Moran, Landhing. M., Doyle, Glenn. A., McNicholas, Laura. F., Cornish, James. W., Kampman, Kyle. M., Preston, Kenzie. L., Berrettini, Wade. H.
Publicado en Pharmacogenomics J (2018)

Extended-Release Naltrexone To Prevent Relapse Among Opioid Dependent, Criminal Justice System Involved Adults: Rationale and Design of a Randomized Controlled Effectiveness Trial

por Lee, Joshua D., Friedmann, Peter D., Boney, Tamara Y., Hoskinson, Randall A., McDonald, Ryan, Gordon, Michael, Fishman, Marc, Chen, Donna T., Bonnie, Richard J., Kinlock, Timothy W., Nunes, Edward V., Cornish, James W., O’Brien, Charles P.
Publicado en Contemp Clin Trials (2015)

Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders

por Lee, Joshua D., Friedmann, Peter D., Kinlock, Timothy W., Nunes, Edward V., Boney, Tamara Y., Hoskinson, Randall A., Wilson, Donna, McDonald, Ryan, Rotrosen, John, Gourevitch, Marc N., Gordon, Michael, Fishman, Marc, Chen, Donna T., Bonnie, Richard J., Cornish, James W., Murphy, Sean M., O’Brien, Charles P.
Publicado en N Engl J Med (2016)